Fisher Lawrence, Fortmann Addie, Knaebel Jennifer, Stuhr Andreas
University of California San Francisco, San Francisco, CA, USA.
Scripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
J Diabetes Sci Technol. 2024 Jan;18(1):99-105. doi: 10.1177/19322968221096163. Epub 2022 May 9.
Evaluations of technology to help adults manage type 2 diabetes (T2D) have yielded mixed results. We analyzed the effectiveness of a free app linked to a glucose meter to study reductions in glucose levels over time among a self-selected sample of adults with T2D.
Adults with T2D >12 months, >21 years, ability to read English (insulin using-IU and non-insulin using-NIU) who independently elected to pair their CONTOUR NEXT ONE meter with the CONTOUR DIABETES App were invited to participate. Glucose data from baseline to 16 weeks were uploaded to the cloud (N = 461). Assessment of diabetes distress, medication taking, quality of life, and hypoglycemia concerns occurred at baseline, six, and 16 weeks.
Findings indicated a significant decrease in weekly glucose levels over time: baseline mean = 169 (62.0) (9.4 mmol/L; 3.44); 16-week mean = 146.5 (36.0) (8.1 mmol/L; 2.0) ( < .001), with no IU and NIU differences. Largest reductions occurred during the first six weeks, with no later rebound effects. Significant, though modest, improvements in global quality of life ( = .03), hypoglycemia concerns ( = .01), and diabetes distress ( < .001) occurred over 16 weeks.
Making an App for monitoring glucose easily available for download with a glucose meter can be helpful for self-selected adults with T2D. Effective utilization assumes that users are sufficiently motivated and engaged, are comfortable and trusting of the technology, and have sufficient knowledge of how to make use of the glucose data.
对帮助成年人管理2型糖尿病(T2D)的技术评估结果不一。我们分析了一款与血糖仪相连的免费应用程序的有效性,以研究在自行选择的T2D成年样本中,随着时间推移血糖水平的降低情况。
邀请病程超过12个月、年龄大于21岁、有英语阅读能力(使用胰岛素-IU和不使用胰岛素-NIU)且自主选择将CONTOUR NEXT ONE血糖仪与CONTOUR DIABETES应用程序配对的T2D成年人参与。从基线到16周的血糖数据上传至云端(N = 461)。在基线、6周和16周时评估糖尿病困扰、用药情况、生活质量和低血糖担忧。
研究结果表明,随着时间推移,每周血糖水平显著下降:基线均值 = 169(62.0)(9.4 mmol/L;3.44);16周均值 = 146.5(36.0)(8.1 mmol/L;2.0)(P <.001),使用胰岛素组和不使用胰岛素组之间无差异。最大降幅出现在前六周,且无后期反弹效应。在16周内,全球生活质量(P =.03)、低血糖担忧(P =.01)和糖尿病困扰(P <.001)均有显著但适度的改善。
使一款用于监测血糖的应用程序可通过血糖仪轻松下载,对自行选择的T2D成年人可能有所帮助。有效利用该应用程序的前提是用户有足够的积极性和参与度,对该技术感到舒适和信任,并且对如何利用血糖数据有足够的了解。